Improving Treatment of Guanidinoacetate Methyltransferase Deficiency: Reduction of Guanidinoacetic Acid in Body Fluids by Arginine Restriction and Ornithine Supplementation

This publication has 17 references indexed in Scilit:

• X-Linked Creatine-Transporter Gene (SLC6A8) Defect: A New Creatine-Deficiency Syndrome
  American Journal of Human Genetics, 2001
• Irreversible brain creatine deficiency with elevated serum and urine creatine: A creatine transporter defect?
  Annals of Neurology, 2001
• Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study
  Molecular Brain Research, 2001
• Neuroprotective effects of creatine administration against NMDA and malonate toxicity
  Brain Research, 2000
• Creatine replacement therapy in guanidineoacetate methyltransferase deficiency, a novel inborn error of metabolism
  The Lancet, 1996
• Creatine Deficiency in the Brain: A New, Treatable Inborn Error of Metabolism
  Pediatric Research, 1994
• Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice
  Journal of the Neurological Sciences, 1992
• Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals
  Metabolism, 1992
• Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture
  Epilepsy Research, 1991
• Effects of α-keto-δ-guanidinovaleric acid on inhibitory amino acid responses on mouse neurons in cell culture
  Brain Research, 1988